NCT01103349View on ClinicalTrials.gov

BI 671800 in Asthmatic Patients on Inhaled Corticosteroids

PHASE2CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

April 20, 2010

Primary Completion Date

August 9, 2011

Study Completion Date

August 9, 2011

Conditions
Asthma
Interventions
DRUG

BI 671800

Double blind randomised parallel group study to assess efficacy and tolerability of BI 617800 in patients with symptomatic asthma

DRUG

Placebo

Patients receive placebo capsules and/or encapsulated tablets

DRUG

Montelukast

Double blind randomised parallel group study to assess efficacy and tolerability of BI 671800 in patients with symptomatic asthma

Trial Locations (53)

Unknown

1268.16.01004 Boehringer Ingelheim Investigational Site, Denver

1268.16.01001 Boehringer Ingelheim Investigational Site, North Dartmouth

1268.16.01006 Boehringer Ingelheim Investigational Site, Plymouth

1268.16.01003 Boehringer Ingelheim Investigational Site, Portland

1268.16.01002 Boehringer Ingelheim Investigational Site, Charleston

1268.16.01005 Boehringer Ingelheim Investigational Site, El Paso

1268.16.43002 Boehringer Ingelheim Investigational Site, Feldbach

1268.16.49018 Boehringer Ingelheim Investigational Site, Aschaffenburg

1268.16.49014 Boehringer Ingelheim Investigational Site, Bamberg

1268.16.49001 Boehringer Ingelheim Investigational Site, Berlin

1268.16.49004 Boehringer Ingelheim Investigational Site, Berlin

1268.16.49010 Boehringer Ingelheim Investigational Site, Berlin

1268.16.49012 Boehringer Ingelheim Investigational Site, Berlin

1268.16.49013 Boehringer Ingelheim Investigational Site, Berlin

1268.16.49016 Boehringer Ingelheim Investigational Site, Berlin

1268.16.49008 Boehringer Ingelheim Investigational Site, Erfurt

1268.16.49005 Boehringer Ingelheim Investigational Site, Frankfurt

1268.16.49015 Boehringer Ingelheim Investigational Site, Frankfurt

1268.16.49011 Boehringer Ingelheim Investigational Site, Hamburg

1268.16.49009 Boehringer Ingelheim Investigational Site, Hanover

1268.16.49017 Boehringer Ingelheim Investigational Site, Hanover

1268.16.49007 Boehringer Ingelheim Investigational Site, Koblenz

1268.16.49006 Boehringer Ingelheim Investigational Site, Lübeck

1268.16.49002 Boehringer Ingelheim Investigational Site, Rüdersdorf

1268.16.49003 Boehringer Ingelheim Investigational Site, Weinheim

1268.16.39006 Boehringer Ingelheim Investigational Site, Ferrara

1268.16.39007 Boehringer Ingelheim Investigational Site, Milan

1268.16.39004 Boehringer Ingelheim Investigational Site, Pietra Ligure (SV)

1268.16.39001 Boehringer Ingelheim Investigational Site, Pisa

1268.16.64001 Boehringer Ingelheim Investigational Site, Christchurch NZ

1268.16.64003 Boehringer Ingelheim Investigational Site, Greenlane East Auckland

1268.16.82008 Boehringer Ingelheim Investigational Site, Anyang

1268.16.82009 Boehringer Ingelheim Investigational Site, Bucheon-si

1268.16.82007 Boehringer Ingelheim Investigational Site, Cheongju-si

1268.16.82006 Boehringer Ingelheim Investigational Site, Daegu

1268.16.82010 Boehringer Ingelheim Investigational Site, Gwangju

1268.16.82001 Boehringer Ingelheim Investigational Site, Seoul

1268.16.82002 Boehringer Ingelheim Investigational Site, Seoul

1268.16.82004 Boehringer Ingelheim Investigational Site, Seoul

1268.16.82005 Boehringer Ingelheim Investigational Site, Seoul

1268.16.82003 Boehringer Ingelheim Investigational Site, Suwon

1268.16.46002 Boehringer Ingelheim Investigational Site, Gothenburg

1268.16.46001 Boehringer Ingelheim Investigational Site, Lund

1268.16.46003 Boehringer Ingelheim Investigational Site, Örebro

1268.16.90002 Boehringer Ingelheim Investigational Site, Bursa

1268.16.90003 Boehringer Ingelheim Investigational Site, Istanbul

1268.16.90004 Boehringer Ingelheim Investigational Site, Istanbul

1268.16.90006 Boehringer Ingelheim Investigational Site, Istanbul

1268.16.90001 Boehringer Ingelheim Investigational Site, Mersin

1268.16.44005 Boehringer Ingelheim Investigational Site, Chertsey

1268.16.44004 Boehringer Ingelheim Investigational Site, London

1268.16.44002 Boehringer Ingelheim Investigational Site, Manchester

1268.16.44003 Boehringer Ingelheim Investigational Site, Southampton

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01103349 - BI 671800 in Asthmatic Patients on Inhaled Corticosteroids | Biotech Hunter | Biotech Hunter